Rift Valley Fever: Clinical Trials

11 trials for Rift Valley Fever, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 recruiting, 2 active not recruiting. 5 Phase 2, 2 Phase 1, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Active not recruiting 1, Recruiting 1
Phase 12Active not recruiting 1, Completed 1
Early Phase 11Completed 1

Follow Rift Valley Fever: new trials by email Literature Review of Rift Valley Fever trials Research Report on Rift Valley Fever

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Dengue, Chikungunya
RecruitingInstitut Pasteur du Cambodge100002025-12-182026-01-22
Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003)
ChAdOx1 RVF, Rabies Vaccine - Rift Valley Fever
Phase 2Active not recruitingUniversity of Oxford2402025-07-082025-11-17
Study to Evaluate Safety, Tolerability and Pharmacokinetics of IDB-011
IDB-011 dose level 1, IDB-011 dose level 2, IDB-011 dose level 3 - Rift Valley Fever
Phase 1Active not recruitingIDBiologics, Inc.402025-04-022026-03-25
RVF and Other Emerging Infectious Diseases in East and Central Africa
Evidence of past or recent RVF exposure - Rift Valley Fever, Hemorrhagic Fevers, Viral
RecruitingWashington State University50002025-02-012026-10-05
A Study to Assess the New Candidate Rift Valley Fever Virus Vaccine in Healthy Adults
ChAdOx1 RVF, Saline - RVF, Rift Valley Fever
Phase 1CompletedUniversity of Oxford302022-05-312023-02-06
Safety and Immunogenicity of a Candidate RVFV Vaccine (RVF001)
ChAdOx1 RVF - Rift Valley Fever
Early Phase 1CompletedUniversity of Oxford152021-06-112023-05-19
Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine
RVF Vaccine - Rift Valley Fever
Phase 2RecruitingU.S. Army Medical Research and Development Command5002018-10-042021-02-11
Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated
Inactivated, Dried (TSI-GSD 200), RVF Vaccine - Rift Valley Fever
Phase 2CompletedU.S. Army Medical Research and Development Command982009-09-012022-03-04
Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine
RVF MP-12 - Rift Valley Fever
Phase 2CompletedU.S. Army Medical Research and Development Command202006-08-012020-01-03
Rift Valley Fever in Kenya
Rift Valley Fever
CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2502006-03-012010-08-27
Safety and Immunogenicity Study of Rift Valley Fever Vaccine
TSI-GSD 200 RVF Vaccine - Rift Valley Fever
Phase 2CompletedU.S. Army Medical Research and Development Command2782004-06-012020-01-03

Narrower conditions

Hemorrhagic Fevers, Viral (3)  ·  Arbovirus Infections (2)  ·  Nervous System Diseases (2)  ·  Virus Diseases (2)  ·  Adenoviridae Infections (1)  ·  Arenaviridae Infections (1)  ·  Brucellosis (1)  ·  Bunyaviridae Infections (1)  ·  Caliciviridae Infections (1)  ·  Chickenpox (1)  ·  Chikungunya Fever (1)  ·  Chlamydia Infections (1)  ·  Communicable Diseases (1)  ·  Communicable Diseases, Emerging (1)

Broader conditions

Animal Diseases (11)  ·  Digestive System Diseases (11)  ·  Hepatitis (11)  ·  Hepatitis, Animal (11)  ·  Hepatitis, Viral, Animal (11)  ·  Infections (11)  ·  Liver Diseases (11)  ·  Mosquito-Borne Diseases (11)  ·  RNA Virus Infections (11)  ·  Bunyaviridae Infections (10)  ·  Vector Borne Diseases (10)  ·  Arbovirus Infections (9)  ·  Virus Diseases (9)  ·  Hemorrhagic Fevers, Viral (8)  ·  Disease Attributes (2)

Interventions

Desiccation (1)  ·  Immunoglobulin M (1)  ·  Rabies Vaccines (1)  ·  Sodium Chloride (1)

Sponsors

U.S. Army Medical Research and Development Command (4)  ·  University of Oxford (3)  ·  IDBiologics, Inc. (1)  ·  Institut Pasteur du Cambodge (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Washington State University (1)

Countries

United States (5)  ·  Kenya (3)  ·  Uganda (2)  ·  Cambodia (1)  ·  Democratic Republic of the Congo (1)  ·  Tanzania (1)  ·  United Kingdom (1)

Top investigators

Adrian VS Hill, Prof (1)  ·  Claude Flamand, Ph.D. (1)  ·  Janice Rusnak, MD (1)  ·  M. Kariuki Njenga, PhD (1)  ·  Phillip Pittman, MD (1)  ·  Pontiano Kaleebu, PhD (1)  ·  Ronald Reisler, MD (1)

Results publications

PMID 37060917, PMID 41237791, PMID 41652539

NIH funding

U01AI151799 (1)